A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

NCT ID: NCT01200394

Last Updated: 2019-03-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

256 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PF-00489791 is an inhibitor of phosphodiesterase type 5. Our hypothesis is that PF-00489791 will enhance the relaxation of blood vessels within the kidney and so reduce blood pressure, improving renal function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Nephropathies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PF-00489791

Group Type EXPERIMENTAL

PF-00489791

Intervention Type DRUG

Tablet, 20 mg once daily for 12 weeks

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Tablet, placebo once daily for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PF-00489791

Tablet, 20 mg once daily for 12 weeks

Intervention Type DRUG

Placebo

Tablet, placebo once daily for 12 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subjects greater than or equal to 18 years. Female subjects must be of non-child bearing potential.
* Clinical diagnosis of type 2 diabetes together with stages 3a, 3b or 4 CKD, based on an eGFR of 25-59 mL/min/1.73m2.
* Evidence of persistent, overt albuminuria; defined as a UACR greater than or equal to 300 mg/g (greater than or equal to 33.9 mg/mmol) for greater than 3 months.

Exclusion Criteria

* Subjects with CKD resulting from type 1 diabetes or non-diabetic CKD.
* Subjects with poorly controlled diabetes mellitus, defined as HbA1C \>9%.
* Subjects on combination ACE inhibitor/ARB therapy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saadat Ansari Internal Medicine

Huntsville, Alabama, United States

Site Status

The Office of Iqbal Saeed MD, LLC

Huntsville, Alabama, United States

Site Status

AKDHC Medical Research Services, LLC*

Glendale, Arizona, United States

Site Status

Southwest Clinical Research Institute, LLC

Tempe, Arizona, United States

Site Status

Southwest Clinical Research Institute, LLC

Tempe, Arizona, United States

Site Status

North America Research Institute

Azusa, California, United States

Site Status

North American Research Institute / California Kidney Specialist

Azusa, California, United States

Site Status

Citrus Dialysis Center

Covina, California, United States

Site Status

California Institute of Renal Research

La Mesa, California, United States

Site Status

Capital Nephrology Clinical Research

Sacramento, California, United States

Site Status

California Kidney Specialists

San Dimas, California, United States

Site Status

American Institute of Research

Whittier, California, United States

Site Status

Whittier Internal Medicine Nephrology Medical Group

Whittier, California, United States

Site Status

North Valley Nephrology

Yuba City, California, United States

Site Status

Riverside Clinical Research

Edgewater, Florida, United States

Site Status

Palm Springs Research Institute

Hialeah, Florida, United States

Site Status

ASA Clinical Research, LLC

Jupiter, Florida, United States

Site Status

Lakeview Medical Research

Summerfield, Florida, United States

Site Status

Rockdale Medical Research Associates

Conyers, Georgia, United States

Site Status

Renal Physicians of Georgia

Macon, Georgia, United States

Site Status

Boise Kidney and Hypertension Institute

Meridian, Idaho, United States

Site Status

Chicago Clinical Research Institute, Inc.

Chicago, Illinois, United States

Site Status

Associates in Nephrology, SC

Evergreen Park, Illinois, United States

Site Status

Research by Design, LLC

Evergreen Park, Illinois, United States

Site Status

RenalCare Associates

Peoria, Illinois, United States

Site Status

Investigative Clinical Research of Indiana, LLC

Elwood, Indiana, United States

Site Status

Kansas Nephrology Research Institute, LLC

Wichita, Kansas, United States

Site Status

Four Rivers Clinical Research, Inc.

Paducah, Kentucky, United States

Site Status

Crescent City Clinical Research Center

Metairie, Louisiana, United States

Site Status

Northwest Louisiana Nephrology

Shreveport, Louisiana, United States

Site Status

Biolab Research, LLC

Rockville, Maryland, United States

Site Status

Alzohaili Medical Consultants

Dearborn, Michigan, United States

Site Status

Apex Medical Research, AMR, Inc.

Flint, Michigan, United States

Site Status

Apex Medical Research, MI, Inc.

Flint, Michigan, United States

Site Status

Clinical Research Consultants, LLC

Kansas City, Missouri, United States

Site Status

Lincoln Nephrology and Hypertension

Lincoln, Nebraska, United States

Site Status

Nebraska Nephrology Research Institute, LLC - Research Management, Inc.

Lincoln, Nebraska, United States

Site Status

Alliance Against Diabetes

Las Vegas, Nevada, United States

Site Status

Clinical Research Consortium

Las Vegas, Nevada, United States

Site Status

Jacobi Medical Center - Department of Medicine - Nephrology

The Bronx, New York, United States

Site Status

Mountain Kidney and Hypertension Associates, PA

Asheville, North Carolina, United States

Site Status

Trial Management Associates

Wilmington, North Carolina, United States

Site Status

Lake Medical Research

Willoughby Hills, Ohio, United States

Site Status

Northeast Clinical Research Center, LLC

Bethlehem, Pennsylvania, United States

Site Status

Preferred Primary Care Physicians, Inc.

Uniontown, Pennsylvania, United States

Site Status

Columbia Nephrology Associates, PA

Columbia, South Carolina, United States

Site Status

Carolina Nephrology, PA

Greenville, South Carolina, United States

Site Status

Palmetto Nephrology, PA

Orangeburg, South Carolina, United States

Site Status

South Carolina Nephrology & Hypertension Ctr, Inc

Orangeburg, South Carolina, United States

Site Status

South Carolina Nephrology and Hypertension Center

Orangeburg, South Carolina, United States

Site Status

Central Texas Kidney Associates

Austin, Texas, United States

Site Status

Research Management, Inc.

Austin, Texas, United States

Site Status

Diagnostic Clinic of Houston, PA

Houston, Texas, United States

Site Status

Houston Nephrology Research

Houston, Texas, United States

Site Status

Research Across America

Houston, Texas, United States

Site Status

Renal Associates, PA

San Antonio, Texas, United States

Site Status

San Antonio Kidney Disease Center Physicians Group, P.L.L.C.

San Antonio, Texas, United States

Site Status

Nephrology Associates of Northern Virginia, Inc.

Fairfax, Virginia, United States

Site Status

Nephrology Specialists, P.C.

Mechanicsville, Virginia, United States

Site Status

Clinical Research Associates of Tidewater

Norfolk, Virginia, United States

Site Status

Renal Remission & Hypertension Consultants, PLLC

Bremerton, Washington, United States

Site Status

Sound Medical Research

Port Orchard, Washington, United States

Site Status

Renal Remission and Hypertension Clinic

Silverdale, Washington, United States

Site Status

Renal Research Practice

Gosford, New South Wales, Australia

Site Status

John Hunter Hospital

Newcastle, New South Wales, Australia

Site Status

Department of Nephrology

New Lambton, Newcastle, Australia

Site Status

Pharmacy Department

New Lambton, Newcastle, Australia

Site Status

Melbourne Renal Research Group

Reservoir, Victoria, Australia

Site Status

Sheldon M Chumir Health Centre

Calgary, Alberta, Canada

Site Status

University of Alberta Hospital

Edmonton, Alberta, Canada

Site Status

Entralogix Clincal Research Inc.

Brampton, Ontario, Canada

Site Status

Entralogix Clinical Research Inc.

Brampton, Ontario, Canada

Site Status

London Health Sciences Centre

London, Ontario, Canada

Site Status

Entralogix Clinical Research Inc.

Oakville, Ontario, Canada

Site Status

N/A - formerly with Entralogix SMO

Toronto, Ontario, Canada

Site Status

Sunnybrook Health Sciences Center

Toronto, Ontario, Canada

Site Status

Centre de sante et de services sociaux champlain-Charles-Le Moyne

Greenfield Park, Quebec, Canada

Site Status

Centre de Dialyse de Bois de Boulogne

Montreal, Quebec, Canada

Site Status

Hopital de Sacre Coeur de Montreal

Montreal, Quebec, Canada

Site Status

Saskatoon Nephrology Group, Nurses Redisence

Saskatoon, Saskatchewan, Canada

Site Status

Saskatoon Nephrology Group, Nurses Residence

Saskatoon, Saskatchewan, Canada

Site Status

Saskatoon Nephrology Group

Saskatoon, Saskatchewan, Canada

Site Status

Aarhus Universitetshospital (Aarhus Sygehus)

Aarhus, , Denmark

Site Status

Rigshospitalet

Copenhagen Oe, , Denmark

Site Status

Steno Diabetes Center

Gentofte Municipality, , Denmark

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Division of Nephrology, Dept. of Medicine

Pokfulam, , Hong Kong

Site Status

Division of Nephrology

Pokfulam, , Hong Kong

Site Status

ICON Clinical Research

Quarry Bay, , Hong Kong

Site Status

Prince of Wales Hospital

Shatin, , Hong Kong

Site Status

Apollo Hospitals

Hyderabad, Andhra Pradesh, India

Site Status

Gujarat Kidney Foundation

Ahmedabad, Gujarat, India

Site Status

Shrushrut Clinical Research Association

Ahmedabad, Gujarat, India

Site Status

P. D. Hinduja National Hospital and Medical Research Centre

Mumbai, Maharashtra, India

Site Status

Pfizer Centre

Mumbai, Maharashtra, India

Site Status

Deenanath Mangeshkar Hospital & Research Centre

Pune, Maharashtra, India

Site Status

Diabetes Care and Research Centre

Pune, Maharashtra, India

Site Status

KE.M Hospital Research Centre

Pune, Maharashtra, India

Site Status

King Edward Memorial Hospital

Pune, Maharashtra, India

Site Status

Jehangir Clinical Development Centre Pvt. Ltd.

Pune, Maharashtra, India

Site Status

Universiti Sains Malaysia

Kota Bharu, Kelantan, Malaysia

Site Status

Unit Kajian Klinikal, Hospital Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Site Status

Hospital Taiping

Taiping, Perak, Malaysia

Site Status

Clinical Research Centre, Hospital Pulau Pinang

George Town, Pulau Pinang, Malaysia

Site Status

Hospital Pulau Pinang

George Town, Pulau Pinang, Malaysia

Site Status

Nephrology Clinic, Queen Elizabeth Hospital

Kota Kinabalu, Sabah, Malaysia

Site Status

Unit Hemodialisis, Hospital Serdang

Kajang, Selangor, Malaysia

Site Status

ICLE SC

Guadalajara, Jalisco, Mexico

Site Status

Comite Mexicano para la Prevencion de la Osteoporosis, A.C.

Mexico City, Mexico City, Mexico

Site Status

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)

Tlalpan, Mexico City, Mexico

Site Status

Hospital Central Dr Ignacio Morones Prieto Unidad Regional de Osteoporosis

San Luis Potosí City, San Luis Potosí, Mexico

Site Status

Hospital Angeles del Pedregal

Angeles Del Pedregal Cp., , Mexico

Site Status

NZOZ "DIAGNOMED" S.C., Poradnia Nefrologiczna

Bielsko-Biala, , Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny im Andrzeja Mieleckiego

Katowice, , Poland

Site Status

NZOZ PS "Medica"

Lublin, , Poland

Site Status

Centrum Medyczne "Osteomed" NZOZ, Lecznica Specjalistow

Warsaw, , Poland

Site Status

Centrum Medyczne "OSTEOMED" NZOZ

Warsaw, , Poland

Site Status

Centrum Medyczne "Osteomed"

Warsaw, , Poland

Site Status

Centrum Medyczne OSTEOMED NZOZ; Lecznica Specjalistaw

Warsaw, , Poland

Site Status

Miedzyleski Szpital Specjalistyczny w Warszawie

Warsaw, , Poland

Site Status

SPZOZ Akademicki Szpital Kliniczny im. J. Mikulicza - Radeckiego

Wroclaw, , Poland

Site Status

Clinical Center of Serbia Institute for Endocrinology, Diabetes and Metabolic Diseases

Belgrade, , Serbia

Site Status

Clinic for Nephrology, Military Medical Academy

Belgrade, , Serbia

Site Status

Clinical Center of Serbia

Belgrade, , Serbia

Site Status

Clinical Hospital Center "Zvezdara"

Belgrade, , Serbia

Site Status

Clinical Hospital Center Zvezdara

Belgrade, , Serbia

Site Status

Clinic for Endocrinology, Clinical Center Nis

Niš, , Serbia

Site Status

FNsP Bratislava, Nemocnica Stare Mesto

Bratislava, , Slovakia

Site Status

Nemocnice s poliklinikami n.o.

Levice, , Slovakia

Site Status

Fakultna nemocnica s poliklinikou J.A.Reimana Presov

Prešov, , Slovakia

Site Status

Vseobecna nemocnica Rimavska Sobota

Rimavská Sobota, , Slovakia

Site Status

Worthwhile Clinical Trials (WWCT), Lake View Hospital

Benoni, Gauteng, South Africa

Site Status

Dr. George Mukhari Hospital -University of Limpopo

Pretoria, Gauteng, South Africa

Site Status

Wits Clinical research

Johannesburg, Gauteng- South Africa, South Africa

Site Status

Centre for Diabetes and Endocrinology

Durban, KwaZulu-Natal, South Africa

Site Status

Latros International

Bloemfontein, , South Africa

Site Status

Division of Nephrology and Hypertension, E13 Renal Unit

Cape Town, , South Africa

Site Status

St Augustine's Hospital

Durban, , South Africa

Site Status

Centre for Diabetes and Endocrinology

Durban, , South Africa

Site Status

Centre for Diabetes and Endocrinology

Houghton, Johannesburg, , South Africa

Site Status

Intercare Parow Medical and Dental Centre

Parow, , South Africa

Site Status

Medi-Clinic Heart Hospital (Pretoria Heart Hospital)

Pretoria, , South Africa

Site Status

Pharmacy

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Clinical Trial Pharmacy

Seongnam-si, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Samsung Medical Center, Department of Pharmacy

Seoul, , South Korea

Site Status

Samsung Medical Center,Sungkyunkwan Univ School of Medicine

Seoul, , South Korea

Site Status

Samsung Medical Center/Division of Nephrology

Seoul, , South Korea

Site Status

Boramae Medical Center/Division of Nephrology

Seoul, , South Korea

Site Status

SMG-SNU Boramae Medical Center

Seoul, , South Korea

Site Status

Sahlgrenska University Hospital Njurmottagningen

Gothenburg, , Sweden

Site Status

A+ Science City site

Stockholm, , Sweden

Site Status

Akademiska Sjukhuset

Uppsala, , Sweden

Site Status

Doncaster Royal Infirmary

Doncaster, South Yorkshire, United Kingdom

Site Status

Research Offices (5th Floor)

Coventry, , United Kingdom

Site Status

University of Edinburgh

Edinburgh, , United Kingdom

Site Status

The Royal London Hospital Whitechapel

London, , United Kingdom

Site Status

Guy's and St Thomas' Foundation Trust

London, , United Kingdom

Site Status

Northern General Hospital Campus

Sheffield, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada Denmark Hong Kong India Malaysia Mexico Poland Serbia Slovakia South Africa South Korea Sweden United Kingdom

Related Links

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-021358-20

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

A7331011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.